AstraZeneca digs into new Cambridge home with MRC drug deal

CAMBRIDGE, England (Reuters) - AstraZeneca, which will complete its move to Cambridge by 2016, is already putting down roots in the ecosystem of the university city as it seeks to revitalize its drug research.

via Reuters: Health News Read More Here..